Elevation Oncology, Inc.
Hedge Funds Holdings

Last updated:

Elevation Oncology, Inc.‘s stocks are currently a part of 9 hedge funds’ portfolios, which represents 26.71% of the total amount of its stocks outstanding. This makes up a total of 6.21M shares of Elevation Oncology, Inc.. Compared to the previous quarter, the number fell by -56.91% or -8.20M shares fewer. As for the holding position changes, 33.33% (3) of current hedge fund investors increased the number of shares held, 33.33% (3) of current holders sold a part of the shares held, and 33.33% (3) closed the holdings completely. 1 hedge funds are new holders of Elevation Oncology, Inc. stock in Q1 2023, it is 11.11% of total holders.

Hedge funds holding Elevation Oncology (Q2 2021 – Q1 2023)

Number of hedge funds
Q2 2021 36
Q3 2021 21
Q4 2021 34
Q1 2022 28
Q2 2022 25
Q3 2022 21
Q4 2022 26
Q1 2023 9

Hedge funds changes in Elevation Oncology positions (Q2 2021 – Q1 2023)

Changes in positions
Q2 2021 360000
Q3 2021 55420-13
Q4 2021 156625
Q1 2022 485101
Q2 2022 28456
Q3 2022 14556
Q4 2022 74429
Q1 2023 1333-1

Top 50 hedge fund holders of Elevation Oncology, Inc. (NASDAQ:ELEV)